TRIA Beauty, Inc. Completes $15.6 Million Initial Close of Growth Financing Investment will be used to significantly expand worldwide commercialization of the TRIA Laser Hair Removal System and TRIA Skin Clarifying System
DUBLIN, Calif., Sept. 10 /PRNewswire/ -- TRIA Beauty, Inc. today announced the initial closing of a Preferred Stock financing. $15.6 million was invested in this initial closing by existing institutional investors Aisling Capital, De Novo Ventures, Technology Partners and Vivo Ventures. TRIA Beauty is a leading provider of light-based at-home beauty solutions. Its products include the TRIA Laser Hair Removal System, the first and only FDA-cleared laser hair removal system available for permanent results at home, and the TRIA Skin Clarifying System, a proprietary at-home acne system clinically proven to clear and prevent breakouts better than popular over-the-counter acne treatments without the harsh side effects of benzoyl peroxide.
"We would like to acknowledge and express our appreciation to our existing investors that have supported us in this latest round of financing," said Kevin Appelbaum, President and CEO of TRIA Beauty, Inc. "This additional invested capital will be used to expand worldwide commercialization of the TRIA Laser Hair Removal System and TRIA Skin Clarifying System. International expansion will be focused on Asia, which has been a very strong market for us."
This press release is neither an offer to purchase nor the solicitation of an offer to sell any securities.
About TRIA Beauty, Inc.
TRIA Beauty brings home the very best in light-based skincare products. In 2008, TRIA Beauty revolutionized the skin care industry with the first and only FDA-cleared hair removal laser available for use at home, the TRIA Laser Hair Removal System. In 2010, TRIA Beauty received clearance from the FDA for a hand-held, high-intensity blue light device also designed for at-home use. TRIA's Skin Clarifying System, the company's patented blue light technology, is FDA-cleared for the treatment of mild to moderate inflammatory acne and launched in the United States in April 2010.
SOURCE TRIA Beauty, Inc.